BioCentury | Jan 4, 2020
Finance

All’s well that ends well

Biotech companies across all market cap tiers posted big gains in the fourth quarter of 2019, with median changes ranging from 7-18%. 4Q19 growth was enough to erase prior quarter losses, putting all tiers in...
BC Week In Review | Sep 3, 2007
Company News

Presidio board of directors update

Presidio Pharmaceuticals Inc. , San Francisco, Calif.   Business: Infectious   Appointed: Srinivas Akkaraju, managing director at Panorama Capital; Felix Baker, managing member at Baker Brothers Advisors LLC; Daniel Perez, venture partner at Bay City Capital;...
Items per page:
1 - 2 of 2
BioCentury | Jan 4, 2020
Finance

All’s well that ends well

Biotech companies across all market cap tiers posted big gains in the fourth quarter of 2019, with median changes ranging from 7-18%. 4Q19 growth was enough to erase prior quarter losses, putting all tiers in...
BC Week In Review | Sep 3, 2007
Company News

Presidio board of directors update

Presidio Pharmaceuticals Inc. , San Francisco, Calif.   Business: Infectious   Appointed: Srinivas Akkaraju, managing director at Panorama Capital; Felix Baker, managing member at Baker Brothers Advisors LLC; Daniel Perez, venture partner at Bay City Capital;...
Items per page:
1 - 2 of 2